CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China - Press Release
SUZHOU, China, Nov. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the researc
Lianshan Zhang Hengrui Pharma Frank Jiang Jiangsu Hengrui Pharmaceuticals Cstone Pharmaceuticals Jiangsu Hengrui Pharmaceuticals Co Ltd
Source: wiredprnews.com